Literature DB >> 33180226

A radiomics pipeline dedicated to Breast MRI: validation on a multi-scanner phantom study.

Marie-Judith Saint Martin1, Fanny Orlhac2, Pia Akl2,3,4, Fahad Khalid2, Christophe Nioche2, Irène Buvat2, Caroline Malhaire2,4, Frédérique Frouin2.   

Abstract

OBJECTIVE: Quantitative analysis in MRI is challenging due to variabilities in intensity distributions across patients, acquisitions and scanners and suffers from bias field inhomogeneity. Radiomic studies are impacted by these effects that affect radiomic feature values. This paper describes a dedicated pipeline to increase reproducibility in breast MRI radiomic studies.
MATERIALS AND METHODS: T1, T2, and T1-DCE MR images of two breast phantoms were acquired using two scanners and three dual breast coils. Images were retrospectively corrected for bias field inhomogeneity and further normalised using Z score or histogram matching. Extracted radiomic features were harmonised between coils by the ComBat method. The whole pipeline was assessed qualitatively and quantitatively using statistical comparisons on two series of radiomic feature values computed in the gel mimicking the normal breast tissue or in dense lesions.
RESULTS: Intra and inter-acquisition variabilities were strongly reduced by the standardisation pipeline. Harmonisation by ComBat lowered the percentage of radiomic features significantly different between the three coils from 87% after bias field correction and MR normalisation to 3% in the gel, while preserving or improving performance of lesion classification in the phantoms. DISCUSSION: A dedicated standardisation pipeline was developed to reduce variabilities in breast MRI, which paves the way for robust multi-scanner radiomic studies but needs to be assessed on patient data.

Entities:  

Keywords:  Breast; Image processing; MRI; Radiologic phantom; Reproducibility

Year:  2020        PMID: 33180226     DOI: 10.1007/s10334-020-00892-y

Source DB:  PubMed          Journal:  MAGMA        ISSN: 0968-5243            Impact factor:   2.310


  37 in total

1.  Texture Analysis with 3.0-T MRI for Association of Response to Neoadjuvant Chemotherapy in Breast Cancer.

Authors:  Na Lae Eun; Daesung Kang; Eun Ju Son; Jeong Seon Park; Ji Hyun Youk; Jeong-Ah Kim; Hye Mi Gweon
Journal:  Radiology       Date:  2019-11-26       Impact factor: 11.105

2.  Radiomic analysis of DCE-MRI for prediction of response to neoadjuvant chemotherapy in breast cancer patients.

Authors:  Ming Fan; Guolin Wu; Hu Cheng; Juan Zhang; Guoliang Shao; Lihua Li
Journal:  Eur J Radiol       Date:  2017-06-28       Impact factor: 3.528

3.  Prediction of malignancy by a radiomic signature from contrast agent-free diffusion MRI in suspicious breast lesions found on screening mammography.

Authors:  Sebastian Bickelhaupt; Daniel Paech; Philipp Kickingereder; Franziska Steudle; Wolfgang Lederer; Heidi Daniel; Michael Götz; Nils Gählert; Diana Tichy; Manuel Wiesenfarth; Frederik B Laun; Klaus H Maier-Hein; Heinz-Peter Schlemmer; David Bonekamp
Journal:  J Magn Reson Imaging       Date:  2017-02-02       Impact factor: 4.813

4.  Radiomics of Multiparametric MRI for Pretreatment Prediction of Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer: A Multicenter Study.

Authors:  Zhenyu Liu; Zhuolin Li; Jinrong Qu; Renzhi Zhang; Xuezhi Zhou; Longfei Li; Kai Sun; Zhenchao Tang; Hui Jiang; Hailiang Li; Qianqian Xiong; Yingying Ding; Xinming Zhao; Kun Wang; Zaiyi Liu; Jie Tian
Journal:  Clin Cancer Res       Date:  2019-03-06       Impact factor: 12.531

5.  Exploring breast cancer response prediction to neoadjuvant systemic therapy using MRI-based radiomics: A systematic review.

Authors:  R W Y Granzier; T J A van Nijnatten; H C Woodruff; M L Smidt; M B I Lobbes
Journal:  Eur J Radiol       Date:  2019-11-06       Impact factor: 3.528

6.  Moral, ethical, and legal dilemmas in the intensive care unit.

Authors:  T A Shragg; T E Albertson
Journal:  Crit Care Med       Date:  1984-01       Impact factor: 7.598

7.  Radiomics Signature on Magnetic Resonance Imaging: Association with Disease-Free Survival in Patients with Invasive Breast Cancer.

Authors:  Hyunjin Park; Yaeji Lim; Eun Sook Ko; Hwan-Ho Cho; Jeong Eon Lee; Boo-Kyung Han; Eun Young Ko; Ji Soo Choi; Ko Woon Park
Journal:  Clin Cancer Res       Date:  2018-06-18       Impact factor: 12.531

8.  MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene Assays.

Authors:  Hui Li; Yitan Zhu; Elizabeth S Burnside; Karen Drukker; Katherine A Hoadley; Cheng Fan; Suzanne D Conzen; Gary J Whitman; Elizabeth J Sutton; Jose M Net; Marie Ganott; Erich Huang; Elizabeth A Morris; Charles M Perou; Yuan Ji; Maryellen L Giger
Journal:  Radiology       Date:  2016-05-05       Impact factor: 11.105

9.  Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI.

Authors:  Nathaniel M Braman; Maryam Etesami; Prateek Prasanna; Christina Dubchuk; Hannah Gilmore; Pallavi Tiwari; Donna Plecha; Anant Madabhushi
Journal:  Breast Cancer Res       Date:  2017-05-18       Impact factor: 6.466

10.  Radiomics: Images Are More than Pictures, They Are Data.

Authors:  Robert J Gillies; Paul E Kinahan; Hedvig Hricak
Journal:  Radiology       Date:  2015-11-18       Impact factor: 11.105

View more
  3 in total

1.  Data harmonisation for information fusion in digital healthcare: A state-of-the-art systematic review, meta-analysis and future research directions.

Authors:  Yang Nan; Javier Del Ser; Simon Walsh; Carola Schönlieb; Michael Roberts; Ian Selby; Kit Howard; John Owen; Jon Neville; Julien Guiot; Benoit Ernst; Ana Pastor; Angel Alberich-Bayarri; Marion I Menzel; Sean Walsh; Wim Vos; Nina Flerin; Jean-Paul Charbonnier; Eva van Rikxoort; Avishek Chatterjee; Henry Woodruff; Philippe Lambin; Leonor Cerdá-Alberich; Luis Martí-Bonmatí; Francisco Herrera; Guang Yang
Journal:  Inf Fusion       Date:  2022-06       Impact factor: 17.564

2.  Expert tumor annotations and radiomics for locally advanced breast cancer in DCE-MRI for ACRIN 6657/I-SPY1.

Authors:  Rhea Chitalia; Sarthak Pati; Megh Bhalerao; Siddhesh Pravin Thakur; Nariman Jahani; Vivian Belenky; Elizabeth S McDonald; Jessica Gibbs; David C Newitt; Nola M Hylton; Despina Kontos; Spyridon Bakas
Journal:  Sci Data       Date:  2022-07-23       Impact factor: 8.501

3.  Test-Retest Data for the Assessment of Breast MRI Radiomic Feature Repeatability.

Authors:  R W Y Granzier; A Ibrahim; S Primakov; S A Keek; I Halilaj; A Zwanenburg; S M E Engelen; M B I Lobbes; P Lambin; H C Woodruff; M L Smidt
Journal:  J Magn Reson Imaging       Date:  2021-12-22       Impact factor: 5.119

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.